mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.1 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |